Implementation of a pharmacist-led intervention to enhance statin prescribing for secondary prevention in primary care: A cluster randomized trial

European Journal of Preventive Cardiology

Volumn 19, Issue 2, 2012, Pages 169-176

  Van De Steeg Van Gompel, Caroline H P A ^a   Wensing, Michel ^a   De Smet, Peter Agm ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Community pharmacy services; health plan implementation; hydroxymethylglutaryl CoA reductase inhibitors; primary health care; secondary prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EDUCATION; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZATION; SECONDARY PREVENTION; TREATMENT INDICATION;

EID: 84864391252     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/1741826711398846     Document Type: Article

References (19)

1. Nederlands Huisartsen Genootschap (NHG). NHG-Standaard Cardiovasculair risicomanagement Last update 2007, [Accessed on 2008] http://nhg.artsennet.nl/ uri/?uri=AMGATE-6059-104-TICH-R183129611676033.
2. Wensing M, Van Lieshout J, Campbell S, Ludt S, Volbracht E, Grol R Berlin: ; June 2009: 41.
3. Larsen J, Andersen M, Bjerrum L, Kragstrup J, Gram LF. Insufficient use of lipid-lowering drugs and measurement of serum cholesterol among patients with a history of myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2003 ; 10: 61-64
4. Autier P, Creplet J, Vansant G, Brohet C, Paquot N, Muls E, et al. The impact of reimbursement criteria on the appropriateness of 'statin' prescribing. Eur J Cardiovasc Prev Rehabil. 2003 ; 10: 456-462 (Pubitemid 39127679)
5. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet. 2003 ; 362: 1225-1230 (Pubitemid 37255352)
6. Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther. 2008 ; 33: 17-23
7. Van der AalstAEimersMWesterhuisG. FTO-peiling 2006. Last update 2007 http://www.medicijngebruik.nl/downloads/FTO-peiling-2006-20070905s.pdf.
8. BooijAEssinkRCambachW. Kwaliteitsindicatoren van het FTO. Last update 2007 http://www.medicijngebruik.nl/downloads/FTO-kwaliteitsindicatoren- 20071123s.pdf.
9. WHO Collaborating Centre for Drug Statistics Methodology. Complete ATC index 2006. Last update 2006, [Accessed on 2006] http://www.whocc.no/atcddd/.
10. Tully MP, Seston EM, Cantrill JA. Motivators and barriers to the implementation of pharmacist-run prescription monitoring and review services in two settings. Int J Pharm Pract. 2000 ; 8: 188-197
11. Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. BrJ Gen Pract. 2003 ; 53: 600-606 (Pubitemid 36944019)
12. Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust. 2003 ; 179: 438-440 (Pubitemid 37328013)
13. Muijrers PE, Knottnerus JA, Sijbrandij J, Janknegt R, Grol RP. Pharmacists in primary care. Determinants of the care-providing function of Dutch community pharmacists in primary care. Pharm World Sci. 2004 ; 26: 256-262 (Pubitemid 39287309)
14. van de Steeg-van Gompel C, Wensing M, De Smet PAGM. Implementation of a discontinuation letter to reduce long-term benzodiazepine use-A cluster randomized trial. Drug Alcohol Depend. 2009 ; 99: 105-114
15. Hickling J, Rogers S, Nazareth I. Barriers to detecting and treating hypercholesterolaemia in patients with ischaemic heart disease: primary care perceptions. Br J Gen Pract. 2005 ; 55: 534-538 (Pubitemid 40903799)
16. AB E, Denig P, van Vliet T, Dekker J. Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study. BMC Family Pract. 2009 ; 10: 24-24
17. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why Don't Physicians Follow Clinical Practice Guidelines? A framework for improvement. JAMA. 1999 ; 282: 1458-1465 (Pubitemid 29493800)
18. Hulscher ME, van Drenth BB, Mokkink HG, van der Wouden JC, Grol RP. Barriers to preventive care in general practice: the role of organizational and attitudinal factors. Br J Gen Pract. 1997 ; 47: 711-714 (Pubitemid 27490069)
19. Leentjens AF, Burgers JS. What factors are important for the successful implementation of guidelines?. Tijdschr Psychiatr. 2008 ; 50: 329-335 (Pubitemid 351972889)